Sign in
4

Changes in Ownership

Adaptimmune Therapeutics PLC Filed Acc 0001104659-20-002081

Chief Operating Officer sold 3,731 shares at $1.20 ($4,477)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Bertrand William C JR Chief Operating Officer 2020-01-06 Sale −3,731 $1.20 $4,477 5,632 D
Open-market sales · 3,731 sh · avg $1.20 · $4,477
Loading xslF345X03/a4.xml…